| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/29/2009 | EP1509206B1 A hemostatic composition |
| 04/29/2009 | EP1487863B1 Process for purifying glycopeptide phospohonate derivatives |
| 04/29/2009 | EP1461357B1 Novel hev antigenic peptide and methods |
| 04/29/2009 | EP1423137B1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 04/29/2009 | EP1399133B1 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 04/29/2009 | EP1383540B1 Methods and pharmaceutical compositions for healing wounds |
| 04/29/2009 | EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 04/29/2009 | EP1343475B1 Self forming, thermodynamically stable liposomes |
| 04/29/2009 | EP1267914B1 Use of lysosomal acid lipase for treating atherosclerosis and related diseases |
| 04/29/2009 | EP1257582B1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1105413B1 Hepatitis c inhibitor tri-peptides |
| 04/29/2009 | EP1051494B1 Methods and reagents for decreasing allergic reactions |
| 04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/29/2009 | CN101421625A mTOR pathway theranostic |
| 04/29/2009 | CN101421299A Peptide vaccine for inducing production of anti-amyloid- -peptide antibody |
| 04/29/2009 | CN101421298A Novel composition and methods for the treatment of immune related diseases |
| 04/29/2009 | CN101421292A HCV inhibitors |
| 04/29/2009 | CN101420977A NOGO receptor antagonists |
| 04/29/2009 | CN101420973A Pharmaceutical compositions comprising SODs and prolamine based peptide fragments |
| 04/29/2009 | CN101420972A Methods for reducing protein aggregation |
| 04/29/2009 | CN101420971A Therapeutic target molecules for the development of novel medicaments for degenerative diseases |
| 04/29/2009 | CN101420970A Implantable sensors and implantable pumps and anti-scarring agents |
| 04/29/2009 | CN101420969A Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 04/29/2009 | CN101420968A Vasodilator |
| 04/29/2009 | CN101420945A Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 04/29/2009 | CN101420933A Paediatric amino acid solution for parenteral nutrition |
| 04/29/2009 | CN101420867A Novel nutraceutical compositions |
| 04/29/2009 | CN101418329A Preparation method of rapeseed proteolysis peptides based on pulse ultrasonic technology and use thereof |
| 04/29/2009 | CN101418046A TAT protein transduction modified NEP1-40 fusion protein and use thereof |
| 04/29/2009 | CN101418039A Novel antibacterial peptide and preparation method and use thereof |
| 04/29/2009 | CN101418036A Rapid purification of gamma trichosanthin and crystallization technology thereof |
| 04/29/2009 | CN101417127A Female capsules capable of invigorating the kidney and moistening the face |
| 04/29/2009 | CN101417126A New use of OMI protein and coding gene thereof |
| 04/29/2009 | CN101417125A Seguo capsules and production method thereof |
| 04/29/2009 | CN101417124A Biocompatible material and process for manufacturing the same |
| 04/29/2009 | CN101417123A Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders |
| 04/29/2009 | CN101417122A Recombination chicken alpha-interferon injection and preparation method thereof |
| 04/29/2009 | CN101417121A Medicine capable of curing skin burning and freezing injury |
| 04/29/2009 | CN101417120A Methods for inducing sustained immune response |
| 04/29/2009 | CN101417119A Medicament composition and package for fast reducing uric acid in blood and use of anserine for fast reducing uric acid in blood |
| 04/29/2009 | CN101416685A Methods for hyperthyroidism in a cat and composition comprising limited iodine |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482793C Characterization of the gsk-3 beta protein and methods of use thereof |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482686C Treatment for diabetes |
| 04/29/2009 | CN100482685C Tolerogenic peptides from myelin basic protein |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482683C Active fragment of human glycine-rich protein and use thereof |
| 04/29/2009 | CN100482682C Novel melanocortin receptor agonists |
| 04/29/2009 | CN100482680C Prodrugs of excitatory amino acids |
| 04/29/2009 | CN100482679C Process of purification of hCG and recombinant hCG purified by that method |
| 04/29/2009 | CN100482674C Reduction of dermal scarring |
| 04/29/2009 | CN100482673C Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 04/29/2009 | CN100482637C Compounds and compositions for delivering active agents |
| 04/29/2009 | CN100482283C Novel chimeric CD154 |
| 04/29/2009 | CN100482272C Dry heat processing stabilizer for prothrombin complex or factor v a IX preparation |
| 04/29/2009 | CN100482239C Method and device for concentrating and stabilising conjugated oestrogens from the urine of mares |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482212C Process for preparing nano liposome for coating large molecular medicine |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524943 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
| 04/28/2009 | US7524940 OB protein compositions and methods |
| 04/28/2009 | US7524937 Reducing body weight or food intake ; binding to antibody |
| 04/28/2009 | US7524936 labeled monoclonal or polyclonal antibodies that preferentially binds oxidoreductase enzyme polypeptides, proteins, fragments, domain peptides or amino acid sequences having replacements, capable of superoxide production |
| 04/28/2009 | US7524935 Sequences characteristic of hypoxia-regulated gene transcription |
| 04/28/2009 | US7524934 Human brain carboxypeptidase B antibodies |
| 04/28/2009 | US7524932 Lactalbumin production process |
| 04/28/2009 | US7524931 Full-length interferon gamma polypeptide variants |
| 04/28/2009 | US7524928 IFN receptor 1 binding proteins |
| 04/28/2009 | US7524927 Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524833 Adsorbent silica gel-containing cartridges are loaded at the site of urine collection and effluent urine is left behind; fully loaded cartridges are collected and transported off-site for processing |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524826 Method of inhibiting the generation of active thrombin on the surface of a cell within an atherosclerotic plaque |
| 04/28/2009 | US7524821 Scaffolded maleimide clusters for multivalent peptide assembly |
| 04/28/2009 | US7524820 Administering one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides, to inhibit neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 04/28/2009 | US7524819 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 04/28/2009 | US7524818 Pure polypeptide of sequence Tyr-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu; controlled release and liposome formulations |
| 04/28/2009 | US7524817 Osteogenic protein/bone morphogenetic proteins of eukaryotic origin |
| 04/28/2009 | US7524816 Peptides and supported peptides for treating skin diseases |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524814 Lactoferrin compositions and methods of wound treatment |
| 04/28/2009 | US7524813 Selectively conjugated peptides and methods of making the same |
| 04/28/2009 | US7524812 A Omega-conopeptide, and the anitoxidant methionine, and either clonidine or baclofen; ziconotide retains its potency and is physically and chemically compatible with the analgesic; for intrathecal administration |
| 04/28/2009 | US7524811 Including the first histidine of the human endostatin protein; antitumor agents; can be combined with a second peptide and zinc |
| 04/28/2009 | US7524674 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera |
| 04/28/2009 | US7524661 Product R; for treating viral infections and stimulating the immune system; immune system disorders |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | US7524628 Method for detecting molecules expressing a selected epitope via fluorescent dyes |
| 04/28/2009 | US7524627 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus |
| 04/28/2009 | US7524622 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
| 04/28/2009 | US7524530 Combining exendin and sucrose with oil phase comprising glycolic acid-lactic acid copolymer in methylene chloride to form emulsion, which is combined with coacervation agent (silicone oil) to form microparticles, transferring to quenching solvent, then hardening; sustained release; shelf life |
| 04/28/2009 | US7524514 Three dimensional, malleable cell culture; tissue engineering; pluripotent cells |
| 04/28/2009 | US7524505 Cell growth factor of hair stem cell factor induces migration of melanocyte stem cells and keratinocyte stem cells to increase in hair follicles, amino acids and vitamins, and minoxidil |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |
| 04/28/2009 | US7524501 Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies |
| 04/28/2009 | US7524500 Method of stimulating stem cells |
| 04/28/2009 | US7524499 Vascular endothelial growth factor fusion comprising fms-related tyrosine kinase 1 (Flt1 receptor ) and immunoglobulin components for use in identifying modulators for decreasing or inhibiting plasma leakage; treating eye disorders |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |